Trade Summary

4 days ago, Gheuens Sarah, serving as Chief Medical Officer at Agios Pharmaceuticals, Inc. (AGIO), sold 2,932 shares at $27.09 per share, for a total transaction value of $79,428.00. Following this transaction, Gheuens Sarah now holds 64,795 shares of AGIO.

This sale represents a 4.00% decrease in Gheuens Sarah's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, December 30, 2025 and publicly disclosed via SEC Form 4 filing on Friday, January 2, 2026, 3 days after the trade was made.

Agios Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.